Escherichia coli in the Americas
Escherichia coli in the Americas [recurso electrónico] /
edited by Alfredo G. Torres.
- XVIII, 384 p. 20 illus., 12 illus. in color. online resource.
1. Enterotoxigenic Escherichia coli -- 2. Enteroaggregative Escherichia coli (EAEC) -- 3. Typical Enteropathogenic Escherichia coli -- 4. Atypical Enteropathogenic Escherichia coli -- 5. Enterohemorrhagic (Shiga toxin-producing) Escherichia coli -- 6. Diffusely Adherent Escherichia coli -- 7. Escherichia coli in Animals -- 8. Escherichia coli in Food Products -- 9. Extra-intestinal Escherichia coli (Uropathogenic E. coli and Avian Pathogenic E. coli) -- 10. Secretion Systems of Pathogenic Escherichia coli -- 11. Therapeutics and Vaccines Against Pathogenic Escherichia coli -- 12. Homeostasis vs Dysbiosis: Role of Commensal Escherichia coli in Disease -- 13. Antibiotic Resistance in Escherichia coli -- 14. Interactions of Pathogenic Escherichia coli With Host Receptors -- 15. Human Diarrheal Infections: Diagnosis of Diarrheagenic Escherichia coli Pathotypes.
Bacterial diarrheal diseases remain an important leading cause of preventable death, especially among children under five in developing countries. In the American continent, diarrheal disease and other health complications caused byEscherichiacoliconstitute a major public health problem, and, therefore, several research groups have dedicated their effort to understand this pathogen and provide feasible solutions to prevent, treat and reduceE. coliinfections. The Latin American Coalition forEscherichia coliResearch (LACER) was created as a multidisciplinary network of international research groups working withE. coliwith the ultimate goal of advancing understanding ofE. coli,and to prepare the next generation of AmericanE. coliinvestigators. As such, this book compiles the knowledge of these investigators aboutE. coli, acommensal bacteria living inside its host, and a pathogen causing disease in animals and humans. Escherichia coli in the Americascontains a series of 15 chapters written by experts, covering basic concepts regarding the different categories ofE. coli, including their environmental niche, virulence mechanisms, host reservoir, and disease outcomes, as well as diagnosis, vaccine development and treatment. This book's target audience include trainees and students learning about the basic and clinical aspects ofE. colipathogenesis, as well as experts around the globe who wish to learn more about this pathogen and the public health impact this bacteria has in America.
9783319450926
Life sciences.
Vaccines.
Drug resistance.
Infectious diseases.
Bacteriology.
Life Sciences.
Bacteriology.
Vaccine.
Infectious Diseases.
Drug Resistance.
QR74.8-99.5
579.3
1. Enterotoxigenic Escherichia coli -- 2. Enteroaggregative Escherichia coli (EAEC) -- 3. Typical Enteropathogenic Escherichia coli -- 4. Atypical Enteropathogenic Escherichia coli -- 5. Enterohemorrhagic (Shiga toxin-producing) Escherichia coli -- 6. Diffusely Adherent Escherichia coli -- 7. Escherichia coli in Animals -- 8. Escherichia coli in Food Products -- 9. Extra-intestinal Escherichia coli (Uropathogenic E. coli and Avian Pathogenic E. coli) -- 10. Secretion Systems of Pathogenic Escherichia coli -- 11. Therapeutics and Vaccines Against Pathogenic Escherichia coli -- 12. Homeostasis vs Dysbiosis: Role of Commensal Escherichia coli in Disease -- 13. Antibiotic Resistance in Escherichia coli -- 14. Interactions of Pathogenic Escherichia coli With Host Receptors -- 15. Human Diarrheal Infections: Diagnosis of Diarrheagenic Escherichia coli Pathotypes.
Bacterial diarrheal diseases remain an important leading cause of preventable death, especially among children under five in developing countries. In the American continent, diarrheal disease and other health complications caused byEscherichiacoliconstitute a major public health problem, and, therefore, several research groups have dedicated their effort to understand this pathogen and provide feasible solutions to prevent, treat and reduceE. coliinfections. The Latin American Coalition forEscherichia coliResearch (LACER) was created as a multidisciplinary network of international research groups working withE. coliwith the ultimate goal of advancing understanding ofE. coli,and to prepare the next generation of AmericanE. coliinvestigators. As such, this book compiles the knowledge of these investigators aboutE. coli, acommensal bacteria living inside its host, and a pathogen causing disease in animals and humans. Escherichia coli in the Americascontains a series of 15 chapters written by experts, covering basic concepts regarding the different categories ofE. coli, including their environmental niche, virulence mechanisms, host reservoir, and disease outcomes, as well as diagnosis, vaccine development and treatment. This book's target audience include trainees and students learning about the basic and clinical aspects ofE. colipathogenesis, as well as experts around the globe who wish to learn more about this pathogen and the public health impact this bacteria has in America.
9783319450926
Life sciences.
Vaccines.
Drug resistance.
Infectious diseases.
Bacteriology.
Life Sciences.
Bacteriology.
Vaccine.
Infectious Diseases.
Drug Resistance.
QR74.8-99.5
579.3
